دورية أكاديمية
أعرض في EDS

The FOXP3 + Pro-Inflammatory T Cell: A Potential Therapeutic Target in Crohn's Disease.

التفاصيل البيبلوغرافية
العنوان: The FOXP3 + Pro-Inflammatory T Cell: A Potential Therapeutic Target in Crohn's Disease.
المؤلفون: Kosinsky RL; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota; Robert Bosch Center for Tumor Diseases, Stuttgart, Germany., Gonzalez MM; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota., Saul D; Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, Minnesota; Department of Trauma and Reconstructive Surgery, Eberhard Karls University Tübingen, BG Trauma Center, Tübingen, Germany., Barros LL; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota; Department of Gastroenterology, University of São Paulo School of Medicine, São Paulo, Brazil., Sagstetter MR; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota., Fedyshyn Y; Department of Physiology, Mayo Clinic, Rochester, Minnesota., Nair A; Division of Computational Biology, Mayo Clinic, Rochester, Minnesota., Sun Z; Division of Computational Biology, Mayo Clinic, Rochester, Minnesota., Hamdan FH; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota., Gibbons HR; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota., Perez Pachon ME; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota., Druliner BR; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota., Johnsen SA; Robert Bosch Center for Tumor Diseases, Stuttgart, Germany., Faubion WA; Division of Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, Arizona. Electronic address: Faubion.william@mayo.edu.
المصدر: Gastroenterology [Gastroenterology] 2024 Apr; Vol. 166 (4), pp. 631-644.e17. Date of Electronic Publication: 2024 Jan 09.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: W.B. Saunders Country of Publication: United States NLM ID: 0374630 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0012 (Electronic) Linking ISSN: 00165085 NLM ISO Abbreviation: Gastroenterology Subsets: MEDLINE
أسماء مطبوعة: Publication: Philadelphia, PA : W.B. Saunders
Original Publication: Baltimore.
مواضيع طبية MeSH: Crohn Disease*/drug therapy , Crohn Disease*/genetics , Crohn Disease*/metabolism, Humans ; Vorinostat/metabolism ; T-Lymphocytes, Regulatory/metabolism ; Inflammation/metabolism ; Forkhead Transcription Factors/genetics ; Forkhead Transcription Factors/metabolism
مستخلص: Background & Aims: The incidence of Crohn's disease (CD) continues to increase worldwide. The contribution of CD4 + cell populations remains to be elucidated. We aimed to provide an in-depth transcriptional assessment of CD4 + T cells driving chronic inflammation in CD.
Methods: We performed single-cell RNA-sequencing in CD4 + T cells isolated from ileal biopsies of patients with CD compared with healthy individuals. Cells underwent clustering analysis, followed by analysis of gene signaling networks. We overlapped our differentially expressed genes with publicly available microarray data sets and performed functional in vitro studies, including an in vitro suppression assay and organoid systems, to model gene expression changes observed in CD regulatory T (Treg) cells and to test predicted therapeutics.
Results: We identified 5 distinct FOXP3 + regulatory Treg subpopulations. Tregs isolated from healthy controls represent the origin of pseudotemporal development into inflammation-associated subtypes. These proinflammatory Tregs displayed a unique responsiveness to tumor necrosis factor-α signaling with impaired suppressive activity in vitro and an elevated cytokine response in an organoid coculture system. As predicted in silico, the histone deacetylase inhibitor vorinostat normalized gene expression patterns, rescuing the suppressive function of FOXP3 + cells in vitro.
Conclusions: We identified a novel, proinflammatory FOXP3 + T cell subpopulation in patients with CD and developed a pipeline to specifically target these cells using the US Food and Drug Administration-approved drug vorinostat.
(Copyright © 2024 AGA Institute. Published by Elsevier Inc. All rights reserved.)
References: Trends Mol Med. 2009 May;15(5):199-207. (PMID: 19362058)
Gastroenterology. 2011 Nov;141(5):1762-72. (PMID: 21889923)
Clin Immunol. 2007 Dec;125(3):281-90. (PMID: 17897887)
Gastroenterology. 2005 Jun;128(7):1868-78. (PMID: 15940622)
BMC Immunol. 2010 Dec 13;11:61. (PMID: 21144017)
Nat Commun. 2021 Feb 17;12(1):1088. (PMID: 33597522)
J Vis Exp. 2015 Mar 06;(97):. (PMID: 25866936)
Cell. 2019 Jun 13;177(7):1888-1902.e21. (PMID: 31178118)
Pharmaceuticals (Basel). 2010 Aug 26;3(9):2751-2767. (PMID: 27713375)
World J Gastroenterol. 2016 Mar 21;22(11):3117-26. (PMID: 27003989)
Nature. 2009 May 14;459(7244):262-5. (PMID: 19329995)
Gastroenterology. 2021 Dec;161(6):1924-1939. (PMID: 34478742)
Dig Dis Sci. 2017 Sep;62(9):2208-2210. (PMID: 28646283)
J Clin Invest. 2008 Jun;118(6):2269-80. (PMID: 18497880)
Nat Immunol. 2003 Apr;4(4):330-6. (PMID: 12612578)
Sci Rep. 2021 Apr 27;11(1):9010. (PMID: 33907256)
J Clin Invest. 2021 Jun 15;131(12):. (PMID: 34128475)
Genome Res. 2003 Nov;13(11):2498-504. (PMID: 14597658)
Nat Biotechnol. 2018 Jun;36(5):411-420. (PMID: 29608179)
Mol Med. 2011 May-Jun;17(5-6):426-33. (PMID: 21365125)
Nat Commun. 2021 Mar 26;12(1):1921. (PMID: 33771991)
Immunity. 2013 Mar 21;38(3):414-23. (PMID: 23521883)
Am J Physiol. 1992 Jun;262(6 Pt 1):L647-61. (PMID: 1616050)
Nat Commun. 2017 Oct 20;8(1):1077. (PMID: 29057876)
Nat Biotechnol. 2014 Apr;32(4):381-386. (PMID: 24658644)
J Biol Chem. 2016 Feb 19;291(8):3759-66. (PMID: 26677228)
Cell. 2019 Sep 5;178(6):1493-1508.e20. (PMID: 31474370)
Nature. 2008 May 8;453(7192):236-40. (PMID: 18368049)
Acta Histochem Cytochem. 2018 Feb 27;51(1):33-40. (PMID: 29622848)
Inflamm Bowel Dis. 2019 Jan 1;25(1):74-77. (PMID: 30016434)
Lancet Gastroenterol Hepatol. 2020 Jan;5(1):17-30. (PMID: 31648971)
Nat Commun. 2023 Feb 22;14(1):993. (PMID: 36813801)
J Immunol. 2010 Apr 1;184(7):3570-81. (PMID: 20181891)
معلومات مُعتمدة: KL2 TR002379 United States TR NCATS NIH HHS; T32 DK007198 United States DK NIDDK NIH HHS; R01 AI089714 United States AI NIAID NIH HHS; K08 DK134759 United States DK NIDDK NIH HHS; P30 DK084567 United States DK NIDDK NIH HHS
فهرسة مساهمة: Keywords: IBD; T Regulatory Cell; scRNA Sequencing
المشرفين على المادة: 58IFB293JI (Vorinostat)
0 (Forkhead Transcription Factors)
0 (FOXP3 protein, human)
تواريخ الأحداث: Date Created: 20240111 Date Completed: 20240325 Latest Revision: 20240602
رمز التحديث: 20240602
مُعرف محوري في PubMed: PMC10960691
DOI: 10.1053/j.gastro.2024.01.007
PMID: 38211712
قاعدة البيانات: MEDLINE
الوصف
تدمد:1528-0012
DOI:10.1053/j.gastro.2024.01.007